These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22152285)

  • 1. Significance of genomic instability in breast cancer in atomic bomb survivors: analysis of microarray-comparative genomic hybridization.
    Oikawa M; Yoshiura K; Kondo H; Miura S; Nagayasu T; Nakashima M
    Radiat Oncol; 2011 Dec; 6():168. PubMed ID: 22152285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of HER2 and C-MYC oncogene amplifications in breast cancer in atomic bomb survivors: associations with radiation exposure and histologic grade.
    Miura S; Nakashima M; Ito M; Kondo H; Meirmanov S; Hayashi T; Soda M; Matsuo T; Sekine I
    Cancer; 2008 May; 112(10):2143-51. PubMed ID: 18348306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity.
    Gunn S; Yeh IT; Lytvak I; Tirtorahardjo B; Dzidic N; Zadeh S; Kim J; McCaskill C; Lim L; Gorre M; Mohammed M
    BMC Cancer; 2010 Jul; 10():396. PubMed ID: 20667129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic instability in the epidermis induced by atomic bomb (A-bomb) radiation: a long-lasting health effect in A-bomb survivors.
    Naruke Y; Nakashima M; Suzuki K; Kondo H; Hayashi T; Soda M; Sekine I
    Cancer; 2009 Aug; 115(16):3782-90. PubMed ID: 19517458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A predictive factor of the quality of microarray comparative genomic hybridization analysis for formalin-fixed paraffin-embedded archival tissue.
    Nakao K; Oikawa M; Arai J; Mussazhanova Z; Kondo H; Shichijo K; Nakashima M; Hayashi T; Yoshiura K; Hatachi T; Nagayasu T
    Diagn Mol Pathol; 2013 Sep; 22(3):174-80. PubMed ID: 23846445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New York.
    Varma G; Varma R; Huang H; Pryshchepava A; Groth J; Fleming D; Nowak NJ; McQuaid D; Conroy J; Mahoney M; Moysich K; Falkner KL; Geradts J
    Br J Cancer; 2005 Sep; 93(6):699-708. PubMed ID: 16222315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization.
    Somiari SB; Shriver CD; He J; Parikh K; Jordan R; Hooke J; Hu H; Deyarmin B; Lubert S; Malicki L; Heckman C; Somiari RI
    Cancer Genet Cytogenet; 2004 Dec; 155(2):108-18. PubMed ID: 15571796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel diagnostic method targeting genomic instability in intracystic tumors of the breast.
    Oikawa M; Yano H; Matsumoto M; Otsubo R; Shibata K; Hayashi T; Abe K; Kinoshita N; Yoshiura K; Nagayasu T
    Breast Cancer; 2015 Sep; 22(5):529-35. PubMed ID: 24402639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide copy number aberrations and HER2 and FGFR1 alterations in primary breast cancer by molecular inversion probe microarray.
    Chen H; Singh RR; Lu X; Huo L; Yao H; Aldape K; Abraham R; Virani S; Mehrotra M; Mishra BM; Bousamra A; Albarracin C; Wu Y; Roy-Chowdhuri S; Kanagal-Shamanna R; Routbort MJ; Medeiros LJ; Patel KP; Broaddus R; Sahin A; Luthra R
    Oncotarget; 2017 Feb; 8(7):10845-10857. PubMed ID: 28125801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of HER-2/neu oncogene amplification detected by fluorescence in situ hybridization in lobular and ductal breast cancer.
    Rosenthal SI; Depowski PL; Sheehan CE; Ross JS
    Appl Immunohistochem Mol Morphol; 2002 Mar; 10(1):40-6. PubMed ID: 11893034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of genomic alterations in radiation-associated breast cancer among childhood cancer survivors, using comparative genomic hybridization (CGH) arrays.
    Yang XR; Killian JK; Hammond S; Burke LS; Bennett H; Wang Y; Davis SR; Strong LC; Neglia J; Stovall M; Weathers RE; Robison LL; Bhatia S; Mabuchi K; Inskip PD; Meltzer P
    PLoS One; 2015; 10(3):e0116078. PubMed ID: 25764003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical role of HER2 gene amplification and chromosome 17: a study on 154 IHC-equivocal cases of invasive breast carcinoma patients.
    Afzal M; Amir M; Hassan MJ; Hussain MS; Aziz MN; Murad S; Murtaza I; Anees M; Sultan A
    Tumour Biol; 2016 Jul; 37(7):8665-72. PubMed ID: 26738861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein overexpression and gene amplification of c-erbB-2 in breast carcinomas: a comparative study of immunohistochemistry and fluorescence in situ hybridization of formalin-fixed, paraffin-embedded tissues.
    Kobayashi M; Ooi A; Oda Y; Nakanishi I
    Hum Pathol; 2002 Jan; 33(1):21-8. PubMed ID: 11823970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of HER2 gene status in breast cancer with HER2 protein overexpression].
    Zeng X; Liang ZY; Wu SF; Zhou WX; Gao J; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):584-8. PubMed ID: 17134563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of HER2 overexpression with gene amplification and its relation to chromosome 17 aneuploidy: a 5-year experience with invasive ductal and lobular carcinomas.
    Nassar A; Khoor A; Radhakrishnan R; Radhakrishnan A; Cohen C
    Int J Clin Exp Pathol; 2014; 7(9):6254-61. PubMed ID: 25337277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved method for analysis of RNA present in long-term preserved thyroid cancer tissue of atomic bomb survivors.
    Hamatani K; Eguchi H; Mukai M; Koyama K; Taga M; Ito R; Hayashi Y; Nakachi K
    Thyroid; 2010 Jan; 20(1):43-9. PubMed ID: 19785523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genomic copy number signature predicts radiation exposure in post-Chernobyl breast cancer.
    Wilke CM; Braselmann H; Hess J; Klymenko SV; Chumak VV; Zakhartseva LM; Bakhanova EV; Walch AK; Selmansberger M; Samaga D; Weber P; Schneider L; Fend F; Bösmüller HC; Zitzelsberger H; Unger K
    Int J Cancer; 2018 Sep; 143(6):1505-1515. PubMed ID: 29663366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic relevance of gene amplifications and coamplifications in breast cancer.
    Al-Kuraya K; Schraml P; Torhorst J; Tapia C; Zaharieva B; Novotny H; Spichtin H; Maurer R; Mirlacher M; Köchli O; Zuber M; Dieterich H; Mross F; Wilber K; Simon R; Sauter G
    Cancer Res; 2004 Dec; 64(23):8534-40. PubMed ID: 15574759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components.
    Marchiò C; Iravani M; Natrajan R; Lambros MB; Geyer FC; Savage K; Parry S; Tamber N; Fenwick K; Mackay A; Schmitt FC; Bussolati G; Ellis I; Ashworth A; Sapino A; Reis-Filho JS
    J Pathol; 2009 Jul; 218(3):301-15. PubMed ID: 19479727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of radiation on the incidence of prostate cancer among Nagasaki atomic bomb survivors.
    Kondo H; Soda M; Mine M; Yokota K
    Cancer Sci; 2013 Oct; 104(10):1368-71. PubMed ID: 23859763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.